The coagulo-lytic system and endothelial function in cyclosporine-treated kidney allograft recipient

被引:74
作者
Malyszko, J [1 ]
Malyszko, JS [1 ]
Pawlak, K [1 ]
Mysliwiec, M [1 ]
机构
[1] MED ACAD BIALYSTOK,DEPT NEPHROL,PL-15540 BIALYSTOK,POLAND
关键词
D O I
10.1097/00007890-199609270-00021
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Since thromboembolic complications in transplanted patients are generally attributed to combined abnormalities in platelets and coagulo-lytic system, some hemostatic parameters tPA (tissue plasminogen activator)tAg and activity, its inhibitor-PAI:Ag and activity, tPA/PAI, thrombin-antithrombin (TAT) and plasmin-antiplasmin complexes (PAP), urokinase-uPA, euglobulin clot lysis time-ECLT, fibrinogen, plasminogen, protein C activity, D-dimer, prothrombin fragments(1+2) (F-1+2), fibrin monomers, fibronectin, lipoprotein-a, and von Willebrand factor[vWF], were evaluated using commercially available kits, The studies were performed on kidney transplant recipients treated with CsA, azathioprine and prednisone (n=21), and healthy volunteers (n=21). ECLT was significantly prolonged in kidney transplant recipients together with a rise in F-1+2, lipoprotein-a, fibrinogen, fibronectin, and vWF when compared with controls, The TPA level was lower, whereas the PAI level was higher in kidney transplant recipients when compared with controls, In conclusion, CsA-treated kidney transplant recipients show evidence of pronounced impairment in fibrinolysis and endothelial damage in comparison with healthy volunteers.
引用
收藏
页码:828 / 830
页数:3
相关论文
共 29 条
[1]  
ANGLESCANO E, 1985, THROMB HAEMOSTASIS, V54, P688
[2]   ENHANCED INVITRO HEMOSTASIS AND REDUCED THROMBOLYSIS IN CYCLOSPORINE-TREATED RENAL-TRANSPLANT RECIPIENTS [J].
BAKER, LRI ;
TUCKER, B ;
KOVACS, IB .
TRANSPLANTATION, 1990, 49 (05) :905-909
[3]  
BARNES JL, 1985, SEMIN NEPHROL, V5, P57
[4]  
BASTIDA E, 1987, BLOOD, V70, P1437
[5]  
BERGSTRAND A, 1985, CLIN NEPHROL, V24, P107
[6]   INCREASED FACTOR-VIII AS AN INDEX OF VASCULAR INJURY IN CYCLOSPORINE NEPHROTOXICITY [J].
BROWN, Z ;
NEILD, GH ;
WILLOUGHBY, JJ ;
SOMIA, NV ;
CAMERON, SJ .
TRANSPLANTATION, 1986, 42 (02) :150-153
[7]   EVIDENCE FOR CHRONIC PLATELET HYPERAGGREGABILITY AND INVIVO ACTIVATION IN CYCLOSPORIN-TREATED RENAL-ALLOGRAFT RECIPIENTS [J].
COHEN, H ;
NEILD, GH ;
PATEL, R ;
MACKIE, IJ ;
MACHIN, SJ .
THROMBOSIS RESEARCH, 1988, 49 (01) :91-101
[8]  
COHEN H, 1988, Fibrinolysis, V2, P197, DOI 10.1016/0268-9499(88)90013-6
[9]  
DROUET L, 1989, THROMB HAEMOSTASIS, V62, P579
[10]   LIPOPROTEIN(A) INHIBITS PLASMINOGEN ACTIVATION IN A TEMPLATE-DEPENDENT MANNER [J].
EDELBERG, JM ;
PIZZO, SV .
BLOOD COAGULATION & FIBRINOLYSIS, 1991, 2 (06) :759-764